70276-72-1

Basic information

• Product Name: N,N'-(1,2-phenylenebis(methylene))dianiline
• Synonyms: N,N'-(1,2-phenylenebis(methylene))dianiline
• CAS NO: 70276-72-1
• Molecular Weight: 288.392
• Mol File: 70276-72-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N,N'-(1,2-phenylenebis(methylene))dianiline(CAS DataBase Reference)
• NIST Chemistry Reference: N,N'-(1,2-phenylenebis(methylene))dianiline(70276-72-1)
• EPA Substance Registry System: N,N'-(1,2-phenylenebis(methylene))dianiline(70276-72-1)

Safety Data

• Hazardous Substances Data: 70276-72-1(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 62-53-3 aniline 
• 91-13-4 α,α'-dibromo-o-xylene 
• 89-92-9 2-methylbenzyl bromide 
• 16497-41-9 N,N'-diphenylphthalamide 
• 88-95-9 Phthaloyl dichloride 
• 122-66-7 diphenyl hydrazine 
• 63546-88-3 2,3-bisphenyl-2,3-dihydrophthalazin-1,4-dione 
• 404-24-0 2,2,2-trifluoro-N-phenylacetamide 

Downstream Products

• 16460-56-3 2,3-diphenyl-1,2,3,4-tetrahydrophthalazine 

Relevant articles and documents

A Nanocrystal Catalyst Incorporating a Surface Bound Transition Metal to Induce Photocatalytic Sequential Electron Transfer Events

Heterogeneous photocatalysis is less common but can provide unique avenues for inducing novel chemical transformations and can also be utilized for energy transductions, i.e., the energy in the photons can be captured in chemical bonds. Here, we developed a novel heterogeneous photocatalytic system that employs a lead-halide perovskite nanocrystal (NC) to capture photons and direct photogenerated holes to a surface bound transition metal Cu-site, resulting in a N-N heterocyclization reaction. The reaction starts from surface coordinated diamine substrates and requires two subsequent photo-oxidation events per reaction cycle. We establish a photocatalytic pathway that incorporates sequential inner sphere electron transfer events, photons absorbed by the NC generate holes that are sequentially funneled to the Cu-surface site to perform the reaction. The photocatalyst is readily prepared via a controlled cation-exchange reaction and provides new opportunities in photodriven heterogeneous catalysis.

CXCR4 ANTAGONISTS FOR THE TREATMENT OF HIV INFECTION

The invention provides compounds, pharmaceutical compositions and methods of use of certain compounds that are antagonists of the chemokine CXCR4 receptor, and in particular to inhibit viral entry of certain viruses. Certain compounds in particular can reduce entry of immunodeficiency virus (HIV) into a cell while not reducing the capacity of stem cells to proliferate, and therefore can be useful for long term treatment regimes. The compounds are useful in particular in the treatment or prevention of HIV infections.